Found 4 matching trials
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer
PHASE2RBS2418 is a specific immune modulator that works through the inhibition of...
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
PHASE1RBS2418 (investigational product) is a specific immune modulator, working t...
Location
Honor Health Research Institute
Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma
PHASE2RBS2418 is a targeted immune modulator that inhibits ectonucleotide pyropho...
Expanded Access RBS2418 Treatment
N/AThis is an expanded access treatment protocol designed to provide access of...
Status
No Longer Available
Location
Multiple Locations